At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 13 enrolled
Drug / intervention
TD-8954 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
In Brief
A Phase 2 clinical trial evaluating TD-8954 and Metoclopramide for Enteral Feeding Intolerance. Completed, enrolled 13 participants across 1 site.
Detailed Summary
This study is being conducted to evaluate the safety, tolerability and early efficacy of IV TD 8954 compared to metoclopramide in critically ill subjects, aged 18 to 85 years, who are admitted to the intensive care require mechanical ventilation, and are intolerant to enteral feeding.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnteral Feeding Intolerance
CountriesAustralia
CollaboratorsTheravance Biopharma
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 2013
Enrollment StartJan 2014
Primary CompletionSep 2014
Study CompletionOct 2014
TodayJul 2026
First PostedSep 30, 2013
Enrollment StartJan 1, 2014
Primary CompletionSep 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.8 years ago
Interventions
TD-8954drug
Metoclopramidedrug